Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STENOTYPE trial of dapagliflozin before CABG surgery
2023-505375-75-00Phase 3Authorised
- Sponsor
- Region Örebro län
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 3, randomised, double-blind trial in Atrial fibrillation (AFib) and acute kidney failure (AKF) comparing Forxiga arm with Placebo arm (2 arms). Primary endpoint: Postoperative atrial fibrillation. Planned start Jan 2024; status: authorised.
02
Drugs
dapagliflozin
03
Conditions
Atrial fibrillation (AFib)acute kidney failure (AKF)
Beyond the preview
Go deeper on 2023-505375-75-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-505375-75-00.